Get the Stockscreener App
105.10
5.41%
-6.0081
Proshares Ultra Nasdaq Biotechnology 2 X Shares stock is traded at $105.10, with a volume of 8,352.
It is down -5.41% in the last 24 hours and down -3.57% over the past month.
See More
Previous Close:
$111.11
Open:
$111.09
24h Volume:
8,352
Relative Volume:
1.08
Market Cap:
$88.29M
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
-5.30%
1M Performance:
-3.57%
6M Performance:
+21.20%
1Y Performance:
+58.73%
1-Day Range:
$104.83
$111.22
1-Week Range:
$103.09
$112.32
52-Week Range:
$65.48
$126.40
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Company Profile
Name
Proshares Ultra Nasdaq Biotechnology 2 X Shares
Sector
Industry
Phone
-
Address
-
Compare BIB vs VOO, IVV, SPY, VTI, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIB
Proshares Ultra Nasdaq Biotechnology 2 X Shares
|
105.10 | 88.29M | 0 | 0 | 0 | 0.00 |
VOO
Vanguard S P 500 Etf
|
701.61 | 1.03T | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
766.67 | 879.75B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
763.25 | 806.09B | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
374.07 | 688.96B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
709.80 | 474.71B | 0 | 0 | 0 | 0.00 |
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Latest News
ETFs Investing in Personalis, Inc. Stocks - TradingView
ETFs Investing in Rocket Pharmaceuticals, Inc. Stocks - TradingView
ETFs Investing in Voyager Therapeutics, Inc. Stocks - tradingview.com
ETFs Investing in Tyra Bioscience, Inc Stocks - TradingView
ETFs Investing in Replimune Group, Inc. Stocks - TradingView
ProShares Ultra Nasdaq Biotechnology declares quarterly distribution of $0.082554 - TradingView
Proshares Ultra Bitcoin ETF (BITU) Stock Price, News, Quote & History - Yahoo! Finance Canada
NYSE Top Gainers Bullish on CryptoETF's on the Run - Investorideas.com
PMV Capital Advisers, LLC's ProShares Ultra S&P500 2x Shares(SSO) Holding History - GuruFocus
How ProShares Ultra QQQ Quietly Built $14.46 Billion in Assets Despite Warnings That Leveraged ETFs Destroy Long-Term Wealth - 24/7 Wall St.
Buy on the Dip Prospects: July 29 Edition - ETF Database
Novavax Inc (NVAX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Design Therapeutics Inc (DSGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pyxis Oncology Inc (PYXS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alnylam Pharmaceuticals Inc (ALNY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nuvalent Inc (NUVL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Allogene Therapeutics Inc (ALLO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Geron Corp (GERN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Oruka Therapeutics Inc (ORKA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Onkure Therapeutics Inc (OKUR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Maravai LifeSciences Holdings Inc (MRVI) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Alumis Inc (ALMS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
EFO Dividend: 1.55% Yield, $1.18/Share — History & Dates - GuruFocus
Evolus Inc (EOLS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Omeros Corp (OMER) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MaxCyte Inc (MXCT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Personalis Inc (PSNL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Abcellera Biologics Inc (ABCL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Avidity Biosciences Inc (RNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
UBR Dividend: 1.69% Yield, $0.51/Share — History & Dates - GuruFocus
Alpha Teknova Inc (TKNO) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Humacyte Inc (HUMA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
UYG Dividend: 9.20% Yield, $10.67/Share — History & Dates - GuruFocus
ProShares Launches First ETF Targeting 2x the Daily Returns of the Nasdaq-100 Equal Weighted Index - Yahoo Finance
SpaceX IPO fuels ETF interest as employee ownership gains traction - scanx.trade
UWM Dividend: 0.69% Yield, $0.53/Share — History & Dates - GuruFocus
Castagnola vs Efstathiou | Prediction Markets - Coinbase
High-Yield Prospects: July 15 Edition - ETF Database
SK Hynix Soars 19% as Leveraged ETFs Launch, Lifting Micron, SanDisk, Western Digital - Yahoo Finance
07/06/2026 ValuEngine Weekly Market Summary & Commentary - The Globe and Mail
07/06/2026 ValuEngine Weekly Market Summary & Commentary - The Globe and Mail
BIBProShares Ultra Nasdaq Biotechnology 2X Shares Volatility & Greeks - Finviz
UJB ETF | ProShares Ultra High Yield 2x Shares - GuruFocus
UJB ETF | ProShares Ultra High Yield 2x Shares - GuruFocus
Yesterday’s Tech Rout Shows How Leveraged ETFs Can Destroy Wealth - Yahoo Finance
Wall Street Technician Declares Financials, Industrials, and Biotech Poised for Breakouts. 3 ETFs Could Soar. - AOL.com
Wall Street Technician Declares Financials, Industrials, and Biotech Poised for Breakouts. 3 ETFs Could Soar. - AOL.com
Mersana Therapeutics Inc (MRSN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Inozyme Pharma Inc (INZY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alnylam Pharmaceuticals Inc (ALNY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Financials Data
There is no financial data for Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.48%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):